Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2
2(40.0%)
Phase 1
2(40.0%)
N/A
1(20.0%)
5Total
Phase 2(2)
Phase 1(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07040605Not ApplicableRecruiting

Deep Cervical Flexor and Sensorimotor Training for Chronic Neck Pain

Role: lead

NCT04381871Phase 2Unknown

Potential Role of Gum Arabic as Immunomodulatory Agent Among COVID 19 Patients

Role: lead

NCT04191213Phase 2Unknown

Gum Arabic as Anti-oxidant, Anti-inflammatory and Fetal Hemoglobin Inducing Agent in Sickle Cell Anemia Patients

Role: lead

NCT02467257Phase 1Completed

Gum Arabic as Fetal Hemoglobin Agent in Sickle Cell Anemia

Role: lead

NCT01319734Phase 1Unknown

Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes Mellitus

Role: lead

All 5 trials loaded